Cargando…

Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction

BACKGROUND: Brain-Derived Neurotrophic Factor (BDNF) is the main candidate for neuroprotective therapy for Huntington's disease (HD), but its conditional administration is one of its most challenging problems. RESULTS: Here we used transgenic mice that over-express BDNF under the control of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giralt, Albert, Carretón, Olga, Lao-Peregrin, Cristina, Martín, Eduardo D, Alberch, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205049/ https://www.ncbi.nlm.nih.gov/pubmed/21985529 http://dx.doi.org/10.1186/1750-1326-6-71

Ejemplares similares

Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington’s Disease
por: Saavedra, Ana, et al.
Publicado: (2013)

Editorial: Metabolic Adaptation to Cell Growth and Proliferation in Normal and Pathological Conditions
por: Giralt, Albert, et al.
Publicado: (2017)

Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy
por: Fernández-García, Sara, et al.
Publicado: (2020)

Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington’s Disease
por: Yu, Chenglong, et al.
Publicado: (2018)

RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington’s Disease
por: Pérez-Sisqués, Leticia, et al.
Publicado: (2021)

Synaptic RTP801 contributes to motor-learning dysfunction in Huntington’s disease
por: Martín-Flores, Núria, et al.
Publicado: (2020)

Caffeine‐mediated BDNF release regulates long‐term synaptic plasticity through activation of IRS2 signaling
por: Lao‐Peregrín, Cristina, et al.
Publicado: (2016)

Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease
por: Gu, Xiaofeng, et al.
Publicado: (2007)

Pathological Conditions of the Urine
Publicado: (1904)

Pathological Conditions of the Urine
Publicado: (1904)

Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons
por: Nekrasov, Evgeny D., et al.
Publicado: (2016)

Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies
por: Brito, V, et al.
Publicado: (2013)

Conditioned taste aversion memory extinction temporally induces insular cortical BDNF release and inhibits neuronal apoptosis
por: Liu, Dian-Wei, et al.
Publicado: (2019)

Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease
por: Potenza, R. L., et al.
Publicado: (2007)

Skeletal muscle pathology in Huntington's disease
por: Zielonka, Daniel, et al.
Publicado: (2014)

Spectrum of Tau Pathologies in Huntington’s disease
por: Baskota, Swikrity Upadhyay, et al.
Publicado: (2019)

Shift work and pathological conditions
por: van Mark, Anke, et al.
Publicado: (2006)

Pathological Condition of the Dental Pulp
por: Cutler, S. P.
Publicado: (1871)

Pathological conditions re-shape physiological Tregs into pathological Tregs
por: Yang, William Y, et al.
Publicado: (2015)

Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model
por: Giralt, Albert, et al.
Publicado: (2017)

Cognitive and Emotional Symptoms Induced by Chronic Stress Are Regulated by EGR1 in a Subpopulation of Hippocampal Pyramidal Neurons
por: Sancho-Balsells, Anna, et al.
Publicado: (2023)

Modelling physiological and pathological conditions to study pericyte biology in brain function and dysfunction
por: Rustenhoven, Justin, et al.
Publicado: (2018)

Huntington’s Disease: Calcium Dyshomeostasis and Pathology Models
por: Kolobkova, Y.A., et al.
Publicado: (2017)

Untangling the Role of Tau in Huntington’s Disease Pathology
por: Salem, Shireen, et al.
Publicado: (2023)

Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions
por: Evans, R.C.
Publicado: (2022)

The Heart Sounds in Normal and Pathological Conditions
Publicado: (1939)

Osteogenic Differentiation in Healthy and Pathological Conditions
por: Valenti, Maria Teresa, et al.
Publicado: (2016)

On Sound as a Cause of Pathological Conditions
por: Bird, Robert
Publicado: (1874)

Salicylic Acid in Pathologic Conditions of the Liver
Publicado: (1907)

Mucins Dynamics in Physiological and Pathological Conditions
por: Melhem, Hassan, et al.
Publicado: (2021)

Dropsy, and the Pathological Conditions That Give Rise to It
por: Davis, N. S.
Publicado: (1863)

The Massage Treatment in Dental Pathological Conditions
por: Rehfuss, W. F.
Publicado: (1890)

Some of the Pathological Conditions of the Oral Cavity
por: Nelles, F. D.
Publicado: (1885)

Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions
por: Bibiloni, Rodrigo, et al.
Publicado: (2010)

Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity
por: Llorach-Pares, Laura, et al.
Publicado: (2020)

Hsp40 overexpression in pacemaker neurons delays circadian dysfunction in a Drosophila model of Huntington's disease
por: Prakash, Pavitra, et al.
Publicado: (2022)

Pyk2 Regulates MAMs and Mitochondrial Dynamics in Hippocampal Neurons
por: López-Molina, Laura, et al.
Publicado: (2022)

Risk-taking and pathological gambling behavior in Huntington’s disease
por: Kalkhoven, Carla, et al.
Publicado: (2014)

Molecular Imaging Markers to Track Huntington’s Disease Pathology
por: Wilson, Heather, et al.
Publicado: (2017)

Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway
por: Barry, Joshua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0l4h8mf18eulsvicjpvev292df